We've found
					184,457 				
					clinical trials				
				
			
		
							
  	
	Pregnancy Clinical Trial
	Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved Reliability
		Status: Enrolling	
	
	
			Updated: 9/16/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Vitiligo Vulgaris Clinical Trial
	Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
		Status: Enrolling
  
							
  	
	Vitiligo Vulgaris Clinical Trial
	Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
		Status: Enrolling	
	
	
			Updated: 12/29/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Other Clinical Trial
	Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Due to Burn Injury
		Status: Enrolling
  
							
  	
	Musculoskeletal, Other Clinical Trial
	Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Due to Burn Injury
		Status: Enrolling	
	
	
			Updated: 8/16/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/3/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Oncology Clinical Trial
	Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 1/14/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acute Promyelocytic Leukemia With PML-RARA Clinical Trial
	Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Acute Promyelocytic Leukemia With PML-RARA Clinical Trial
	Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurofibromatosis Type 1 Clinical Trial
	Neurofibromatosis Type 1 Patient Registry
		Status: Enrolling
  
							
  	
	Neurofibromatosis Type 1 Clinical Trial
	Neurofibromatosis Type 1 Patient Registry
		Status: Enrolling	
	
	
			Updated: 12/7/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Neurology Clinical Trial
	Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Neurology Clinical Trial
	Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism
		Status: Enrolling	
	
	
			Updated: 8/4/2011	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology Clinical Trial
	Exploring Advanced Imaging Techniques to Characterize Botulinum Toxin Diffusion in Human Muscle
		Status: Enrolling
  
							
  	
	Neurology Clinical Trial
	Exploring Advanced Imaging Techniques to Characterize Botulinum Toxin Diffusion in Human Muscle
		Status: Enrolling	
	
	
			Updated: 3/8/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 SYSTEMIC SCLERODERMA Clinical Trial
	Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II
  
							
  	
	SYSTEMIC SCLERODERMA Clinical Trial
	Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 SYSTEMIC SCLERODERMA Clinical Trial
	Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II
  
							
  	
	SYSTEMIC SCLERODERMA Clinical Trial
	Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 SYSTEMIC SCLERODERMA Clinical Trial
	Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II
  
							
  	
	SYSTEMIC SCLERODERMA Clinical Trial
	Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 SYSTEMIC SCLERODERMA Clinical Trial
	Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II
  
							
  	
	SYSTEMIC SCLERODERMA Clinical Trial
	Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 SYSTEMIC SCLERODERMA Clinical Trial
	Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II
  
							
  	
	SYSTEMIC SCLERODERMA Clinical Trial
	Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	
	
			Updated: 11/19/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	
	
			Updated: 11/19/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	
	
			Updated: 11/19/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	
	
			Updated: 11/19/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	
	
			Updated: 11/19/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	
	
			Updated: 11/19/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	
	
			Updated: 11/19/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	
	
			Updated: 11/19/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	
	
			Updated: 11/19/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	
	
			Updated: 11/19/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	
	
			Updated: 11/19/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 1/29/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 
  
						
				
			
We've found
					184,457 
				
					clinical trials
				
				
				
	Pregnancy Clinical Trial
	
Updated: 9/16/2013
  
  
  Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved Reliability
		Status: Enrolling	
	Updated: 9/16/2013
Click here to add this to my saved trials
	    
	 
  	
	Vitiligo Vulgaris Clinical Trial
	
Updated: 12/29/2015
  
  
  Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
		Status: Enrolling	
	Updated: 12/29/2015
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Other Clinical Trial
	
Updated: 8/16/2012
  
  
  Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Due to Burn Injury
		Status: Enrolling	
	Updated: 8/16/2012
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 2/3/2016
  
  
  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/3/2016
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 1/14/2016
  
  
  Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 1/14/2016
Click here to add this to my saved trials
	    
	 
  	
	Acute Promyelocytic Leukemia With PML-RARA Clinical Trial
	
Updated: 12/31/1969
  
  
  Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurofibromatosis Type 1 Clinical Trial
	
Updated: 12/7/2015
  
  
  Neurofibromatosis Type 1 Patient Registry
		Status: Enrolling	
	Updated: 12/7/2015
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Neurology Clinical Trial
	
Updated: 8/4/2011
  
  
  Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism
		Status: Enrolling	
	Updated: 8/4/2011
Click here to add this to my saved trials
	    
	 
  	
	Neurology Clinical Trial
	
Updated: 3/8/2012
  
  
  Exploring Advanced Imaging Techniques to Characterize Botulinum Toxin Diffusion in Human Muscle
		Status: Enrolling	
	Updated: 3/8/2012
Click here to add this to my saved trials
	    
	 
  	
	SYSTEMIC SCLERODERMA Clinical Trial
	
Updated: 12/31/1969
  
  
  Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	SYSTEMIC SCLERODERMA Clinical Trial
	
Updated: 12/31/1969
  
  
  Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	SYSTEMIC SCLERODERMA Clinical Trial
	
Updated: 12/31/1969
  
  
  Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	SYSTEMIC SCLERODERMA Clinical Trial
	
Updated: 12/31/1969
  
  
  Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	SYSTEMIC SCLERODERMA Clinical Trial
	
Updated: 12/31/1969
  
  
  Scleroderma Treatment With Autologous Transplant (STAT) Study
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 11/19/2015
  
  
  PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	Updated: 11/19/2015
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 11/19/2015
  
  
  PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	Updated: 11/19/2015
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 11/19/2015
  
  
  PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	Updated: 11/19/2015
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 11/19/2015
  
  
  PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	Updated: 11/19/2015
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 11/19/2015
  
  
  PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	Updated: 11/19/2015
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 11/19/2015
  
  
  PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	Updated: 11/19/2015
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 11/19/2015
  
  
  PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	Updated: 11/19/2015
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 11/19/2015
  
  
  PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	Updated: 11/19/2015
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 11/19/2015
  
  
  PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	Updated: 11/19/2015
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 11/19/2015
  
  
  PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	Updated: 11/19/2015
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 11/19/2015
  
  
  PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
		Status: Enrolling	
	Updated: 11/19/2015
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 1/29/2014
  
  
  Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 1/29/2014
Click here to add this to my saved trials
	    
	